The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages

Simcha Marcovitch*, Yona Keisari

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

The anticancer drugs adriamycin (ADR) and actinomycin D (AMD) were tested for their effect on the oxidative burst (OB) of mouse peritoneal macrophages (MPM) and on the killing of tumor cells by OB-stimulated MPM. The oxidative burst of MPM determined by hydrogen peroxide (H2O2) production was severely impaired by ADR (10 μg/ml) and AMD (40 μg/ml) after a 1 h treatment and by lower concentrations of the drugs following a 24 h treatment. The toxicity of the drugs against MPM was comparable to their effect on EL4 cells. Pretreatment of EL4 and TLX-9 tumor cells with sublethal amounts of ADR for 4 h rendered the cells sensitive to the cytotoxic effect of OB-stimulated MPM which were otherwise unable to kill these cells. It seems that anticancer drugs and OB-stimulated macrophages can cooperate in the destruction of tumor cells in vitro.

Original languageEnglish
Pages (from-to)205-208
Number of pages4
JournalCancer Immunology, Immunotherapy
Volume20
Issue number3
DOIs
StatePublished - Dec 1985

Fingerprint

Dive into the research topics of 'The synergistic tumoricidal activity of anticancer drugs and oxidative burst-triggered macrophages'. Together they form a unique fingerprint.

Cite this